INNT
TOTAL INVALIDATION PROCESSED BY THE IB
01/02/2025
Voltar para busca
Dado oficial do USPTO
SNPFITR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
01/02/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 10, 44
Data de depósito
27/06/2016
Data de registro
19/09/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/04/2024
Última transação
01/02/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
11
Localização do titular
GB
Examinador
KENEALY, NATALIE
Unidade examinadora
L40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Cytox Limited
Representantes
Darren M. Geliebter Lombard & Geliebter LLP
Classificação técnica
Classes Nice
Classe 9Classe 10Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Computer software for the analysis of data relating to the medical industry; computer software for the analysis of biological data in the nature of genotyping databiomarker data and other data from the analysis of mammalian fluidcell and tissue samples; computer software for the analysis of data for use in the provision of diagnostic and prognostic servicesin the field ofAlzheimer's disease and diagnostic and prognostic services for use in the assessment of risk of developing diseaseAlzheimer's disease; computer software for analysis of genetic polymorphisms; computer software for the assessment of risk of developing diseaseAlzheimer's disease
Classe 10
Medical apparatus being sample plates for medical purposes; array plates for medical purposes; 96 well plates for medical purposes; medical apparatus for use in diagnostic and prognostic servicesAlzheimer's disease diagnostic and prognostic services; medical apparatusarray plates for detection of genetic polymorphisms; medical apparatus for genotyping
Classe 44
Provision of information and advice relating to healthcare and the medical industryproviding medical information and adviceproviding healthcare advice and information; genetic testing for medical purposesdiagnostic and genotyping services and recordal and collation of data and data analysis thereof for medical purposes; genetic testing for medical purposesinterpretation and provision of results of the aforementioned data; services for the diagnosis and prognosis of diseaseAlzheimer's disease; services for the determination of genetic polymorphismsgenetic testing for medical purposes; medical consultation servicesservices for the assessment of risk of developing disease such as Alzheimer's disease; medical consultation servicesservices for the assessment of the usefulness of medicines for treating or preventing disease such as Alzheimer's disease
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
15/01/2025
INPC
INVALIDATION PROCESSED
14/01/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
06/12/2024
C71T
CANCELLED SECTION 71
05/04/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
19/09/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
16/07/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
13/11/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/07/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
20/09/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/02/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/01/2018
FIMP
FINAL DISPOSITION PROCESSED
11/01/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
19/12/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
19/09/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/07/2017
PUBO
PUBLISHED FOR OPPOSITION
04/07/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/06/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/06/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
31/05/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/05/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/05/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/05/2017
ALIE
ASSIGNED TO LIE
24/05/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/05/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/04/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/04/2017
RFNT
REFUSAL PROCESSED BY IB
18/11/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/11/2016
RFRR
REFUSAL PROCESSED BY MPU
03/11/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/10/2016
CNRT
NON-FINAL ACTION WRITTEN
12/10/2016
DOCK
ASSIGNED TO EXAMINER
05/10/2016
MAFR
APPLICATION FILING RECEIPT MAILED
30/09/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/09/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
22/09/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SNPFITR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.